|
Rescue medications for sacituzumab tirumotecan Clinical Trials
1 actively recruiting trial across 1 location
No change since May 2026
Traverse City, Michigan1 trial
A Clinical Trial of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) to Treat Urothelial Cancer (MK-2870-031)
Munson Medical Center ( Site 0812)
Phase 3
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.